These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 12682816)

  • 1. Rifampin-impregnated silicone catheters: a potential tool for prevention and treatment of CSF shunt infections.
    Hampl JA; Weitzel A; Bonk C; Kohnen W; Roesner D; Jansen B
    Infection; 2003 Mar; 31(2):109-11. PubMed ID: 12682816
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Initial experience with antibiotic-impregnated silicone catheters for shunting of cerebrospinal fluid in children.
    Aryan HE; Meltzer HS; Park MS; Bennett RL; Jandial R; Levy ML
    Childs Nerv Syst; 2005 Jan; 21(1):56-61. PubMed ID: 15480705
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Do antibiotic-impregnated shunts in hydrocephalus therapy reduce the risk of infection? An observational study in 258 patients.
    Ritz R; Roser F; Morgalla M; Dietz K; Tatagiba M; Will BE
    BMC Infect Dis; 2007 May; 7():38. PubMed ID: 17488498
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of antibiotic-impregnated shunt catheters in decreasing the incidence of shunt infection in the treatment of hydrocephalus.
    Sciubba DM; Stuart RM; McGirt MJ; Woodworth GF; Samdani A; Carson B; Jallo GI
    J Neurosurg; 2005 Aug; 103(2 Suppl):131-6. PubMed ID: 16370278
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduction in shunt infection using antibiotic impregnated CSF shunt catheters: an Australian prospective study.
    Pattavilakom A; Xenos C; Bradfield O; Danks RA
    J Clin Neurosci; 2007 Jun; 14(6):526-31. PubMed ID: 17430776
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro and in vivo efficacy of a rifampin-loaded silicone catheter for the prevention of CSF shunt infections.
    Hampl J; Schierholz J; Jansen B; Aschoff A
    Acta Neurochir (Wien); 1995; 133(3-4):147-52. PubMed ID: 8748757
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibiotic resistant infections with antibiotic-impregnated Bactiseal catheters for ventriculoperitoneal shunts.
    Demetriades AK; Bassi S
    Br J Neurosurg; 2011 Dec; 25(6):671-3. PubMed ID: 21707238
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Infection rate with application of an antibiotic-impregnated catheter for shunt implantation in children - a retrospective analysis.
    Eymann R; Steudel WI; Kiefer M
    Klin Padiatr; 2009; 221(2):69-73. PubMed ID: 19263325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of scanning electron microscopy to investigate the prophylactic efficacy of rifampin-impregnated CSF shunt catheters.
    Kockro RA; Hampl JA; Jansen B; Peters G; Scheihing M; Giacomelli R; Kunze S; Aschoff A
    J Med Microbiol; 2000 May; 49(5):441-450. PubMed ID: 10798557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment and prevention of infections of cerebrospinal fluid shunts.
    Fan-Havard P; Nahata MC
    Clin Pharm; 1987 Nov; 6(11):866-80. PubMed ID: 3315400
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Infection of the valves of CSF shunts. Results of local and general antibiotic treatment in 6 cases].
    Roualdes G; Lartigue C; Boudigue MD; Maissin F
    Neurochirurgie; 1985; 31(5):390-4. PubMed ID: 4088406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduction in external ventricular drain infection rate. Impact of a minimal handling protocol and antibiotic-impregnated catheters.
    Rivero-Garvía M; Márquez-Rivas J; Jiménez-Mejías ME; Neth O; Rueda-Torres AB
    Acta Neurochir (Wien); 2011 Mar; 153(3):647-51. PubMed ID: 21170556
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of an antibiotic-impregnated shunt system for the treatment of hydrocephalus.
    Govender ST; Nathoo N; van Dellen JR
    J Neurosurg; 2003 Nov; 99(5):831-9. PubMed ID: 14609161
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of antibiotic-impregnated shunts on infection rate in adult hydrocephalus: a single institution's experience.
    Farber SH; Parker SL; Adogwa O; McGirt MJ; Rigamonti D
    Neurosurgery; 2011 Sep; 69(3):625-9; discussion 629. PubMed ID: 21499157
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hospital costs associated with shunt infections in patients receiving antibiotic-impregnated shunt catheters versus standard shunt catheters.
    Attenello FJ; Garces-Ambrossi GL; Zaidi HA; Sciubba DM; Jallo GI
    Neurosurgery; 2010 Feb; 66(2):284-9; discussion 289. PubMed ID: 20087127
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of complicated shunt infections: a clinical report.
    James HE; Bradley JS
    J Neurosurg Pediatr; 2008 Mar; 1(3):223-8. PubMed ID: 18352767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characteristics and treatment outcome of cerebrospinal fluid shunt-associated infections in adults: a retrospective analysis over an 11-year period.
    Conen A; Walti LN; Merlo A; Fluckiger U; Battegay M; Trampuz A
    Clin Infect Dis; 2008 Jul; 47(1):73-82. PubMed ID: 18484878
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the efficacies of antibiotic-impregnated and silver-impregnated ventricular catheters on the prevention of infections. An in vitro laboratory study.
    Secer HI; Kural C; Kaplan M; Kilic A; Duz B; Gonul E; Izci Y
    Pediatr Neurosurg; 2008; 44(6):444-7. PubMed ID: 19018152
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and economic consequences of antibiotic-impregnated cerebrospinal fluid shunt catheters.
    Eymann R; Chehab S; Strowitzki M; Steudel WI; Kiefer M
    J Neurosurg Pediatr; 2008 Jun; 1(6):444-50. PubMed ID: 18518694
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Shunt infections: prevention and treatment.
    Chapman PH; Borges LF
    Clin Neurosurg; 1985; 32():652-64. PubMed ID: 3905157
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.